Clinical Investigation to Examine Toothpaste Effect on Oral Bacteria
Study Details
Study Description
Brief Summary
The primary objective was to evaluate the antibacterial effects of two toothpastes containing 0.3% triclosan, 2% copolymer and 0.234% sodium fluoride in a silica base as compared to a control regular fluoride toothpaste on anaerobic and malodor bacteria 12 hours after 13 days of product use. A secondary objective was to demonstrate that a toothpaste containing 0.3% triclosan, 2% copolymer, 0.234% sodium fluoride and a flavor with odor-masking ingredients in silica base (Colgate Total Toothpaste-Flavor Option 1) provides a level of antibacterial efficacy that is "equivalent" to a toothpaste containing 0.3% triclosan, 2% copolymer, 0.234% sodium fluoride and a regular flavor in silica base (Colgate Total Toothpaste-Flavor Option 2) after 13 days of product use.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Total Flavor Option 1 Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM (oral malodor) complex 1 ingredient - Total Flavor Option 1 |
Drug: Total Flavor option 1
Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient -Total Flavor Option 1
Other Names:
|
Experimental: Total Flavor Option 2 Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM (oral malodor) complex 2 ingredient. Total Flavor Option 2 |
Drug: Total Flavor option 2
Total toothpaste containing triclosan/copolymer/sodium fluoride and new OM complex 2 ingredient. Total Flavor option 2
Other Names:
|
Placebo Comparator: Crest Toothpaste Placebo toothpaste: Crest Cavity Protection toothpaste (currently marketed) |
Drug: Placebo toothpaste: Crest Cavity Protection toothpaste
Placebo toothpaste: Crest Cavity Protection toothpaste w/sodium fluoride (currently marketed)
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Anaerobic Bacteria [Baseline]
Subjects brush their teeth with assigned toothpaste 2x/day for 13 days. On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation. Samples of dental plaque at the gumline will be collected for microbiological analysis to determine total levels of anaerobic bacteria CFU - colony forming units.
- Anaerobic Bacteria [12 hours]
Subjects brush their teeth with assigned toothpaste 2x/day for 13 days. On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation. Samples of dental plaque at the gumline will be collected for microbiological analysis to determine total levels of anaerobic bacteria CFU - colony forming units.
- Malodor Bacteria (Breath Odor Causing Bacteria) [Baseline]
Subjects brush their teeth with assigned toothpaste 2x/day for 13 days. On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation. Samples of dental plaque at the gumline will be collected for microbiological analysis to determine levels of mouth odor causing bacteria CFU - colony forming units.
- Malodor Bacteria (Breath Odor Causing Bacteria) [12 hours]
Subjects brush their teeth with assigned toothpaste 2x/day for 13 days. On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation. Samples of dental plaque at the gumline will be collected for microbiological analysis to determine levels of mouth odor causing bacteria CFU - colony forming units.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Males and females in good general health aged 18 to 70 years.
-
A willingness to read, understand, and sign the Informed Consent Form after the nature of the study has been fully explained to them. Subject should demonstrate a willingness to comply with all study procedures and sampling schedules.
-
A minimum of 20 natural teeth with facial and lingual scorable surfaces.
-
Adequate oral hygiene and no signs of oral neglect.
-
Good periodontal health. Enrolled subjects will have no more than five periodontal pockets of 5 mm.
-
Subjects with gingival index greater than or equal to 1.0 (Loe-Silness Index) and plaque index greater than or equal to 1.5 (Turesky modification of Quigley-Hein Index) will be enrolled.
Exclusion Criteria:
-
History of significant adverse effects following use of oral hygiene products such as toothpastes and mouthrinses. Allergy to personal care/consumer products or their ingredients.
-
Teeth that are grossly carious, fully crowned or extensively restored on facial and/or lingual surfaces, orthodontically banded, abutments, or third molars
-
History of diabetes or hepatic or renal disease, or other serious medical conditions or transmittable diseases, e.g. heart disease or AIDS.
-
History of rheumatic fever, heart murmur, mitral valve prolapse or other conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures.
-
Subjects on antibiotic, anti-inflammatory or anticoagulant therapy during the month preceding the baseline exam.
-
Significant oral soft tissue pathology, systemically related gingival enlargement, severe gingivitis (based on a visual examinations).
-
History of active severe periodontal disease with bleeding gums and loose teeth.
-
Gross dental caries, severe generalized cervical abrasion and/or enamel abrasion, large fractured or temporary restorations (based on visual examinations).will not be included in the tooth count.
-
Fixed or removable orthodontic appliance or removable partial dentures.
-
Participation in a dental plaque/gingivitis clinical study involving oral care products, within the last 30 days. History of dental prophylaxis or treatments in the past month.
-
Self reported pregnancy or lactation.
-
History or current use of objects to pierce the lips or tongue.
-
Subjects known to be an alcoholic, or a recovering alcoholic.
-
History or current use of recreational drugs.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Rutgers School of Dental Medicine | Newark | New Jersey | United States | 07107 |
Sponsors and Collaborators
- Colgate Palmolive
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CRO-1113-BACT-PS-NJ
Study Results
Participant Flow
Recruitment Details | subject recruitment is completed locally at the clinical site |
---|---|
Pre-assignment Detail | There will be a one (1) week wash out phase with commercially available fluoride toothpaste prior to any study intervention being assigned. |
Arm/Group Title | Total Flavor Option 1 | Total Flavor Option 2 | Crest Toothpaste |
---|---|---|---|
Arm/Group Description | Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient - Total Flavor Option 1 Total Flavor option 1: Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient -Total Flavor Option 1 | Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 2 ingredient. Total Flavor Option 2 Total Flavor option 2: Total toothpaste containing triclosan/copolymer/sodium fluoride and new OM complex 2 ingredient. Total Flavor option 2 | Placebo toothpaste: Crest Cavity Protection toothpaste (currently marketed) Placebo toothpaste: Crest Cavity Protection toothpaste: Placebo toothpaste: Crest Cavity Protection toothpaste w/sodium fluoride (currently marketed) |
Period Title: Overall Study | |||
STARTED | 43 | 42 | 43 |
COMPLETED | 37 | 36 | 34 |
NOT COMPLETED | 6 | 6 | 9 |
Baseline Characteristics
Arm/Group Title | Total Flavor Option 1 | Total Flavor Option 2 | Crest Toothpaste | Total |
---|---|---|---|---|
Arm/Group Description | Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient - Total Flavor Option 1 Total Flavor option 1: Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient -Total Flavor Option 1 | Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 2 ingredient. Total Flavor Option 2 Total Flavor option 2: Total toothpaste containing triclosan/copolymer/sodium fluoride and new OM complex 2 ingredient. Total Flavor option 2 | Placebo toothpaste: Crest Cavity Protection toothpaste (currently marketed) Placebo toothpaste: Crest Cavity Protection toothpaste: Placebo toothpaste: Crest Cavity Protection toothpaste w/sodium fluoride (currently marketed) | Total of all reporting groups |
Overall Participants | 43 | 42 | 43 | 128 |
Age (years) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [years] |
36.6
(10.2)
|
34.2
(10.34)
|
35.9
(12.08)
|
35.4
(10.82)
|
Sex: Female, Male (Count of Participants) | ||||
Female |
28
65.1%
|
29
69%
|
24
55.8%
|
81
63.3%
|
Male |
15
34.9%
|
13
31%
|
19
44.2%
|
47
36.7%
|
Region of Enrollment (participants) [Number] | ||||
United States |
43
100%
|
42
100%
|
43
100%
|
128
100%
|
Outcome Measures
Title | Anaerobic Bacteria |
---|---|
Description | Subjects brush their teeth with assigned toothpaste 2x/day for 13 days. On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation. Samples of dental plaque at the gumline will be collected for microbiological analysis to determine total levels of anaerobic bacteria CFU - colony forming units. |
Time Frame | Baseline |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Total Flavor Option 1 | Total Flavor Option 2 | Crest Toothpaste |
---|---|---|---|
Arm/Group Description | Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient - Total Flavor Option 1 Total Flavor option 1: Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient -Total Flavor Option 1 | Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 2 ingredient. Total Flavor Option 2 Total Flavor option 2: Total toothpaste containing triclosan/copolymer/sodium fluoride and new OM complex 2 ingredient. Total Flavor option 2 | Placebo toothpaste: Crest Cavity Protection toothpaste (currently marketed) Placebo toothpaste: Crest Cavity Protection toothpaste: Placebo toothpaste: Crest Cavity Protection toothpaste w/sodium fluoride (currently marketed) |
Measure Participants | 43 | 42 | 43 |
Mean (Standard Deviation) [colony forming units] |
8.40
(0.33)
|
8.42
(0.25)
|
8.43
(0.28)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Total Flavor Option 1, Total Flavor Option 2, Crest Toothpaste |
---|---|---|
Comments | The null hypothesis states that there is no difference between groups. | |
Type of Statistical Test | Superiority or Other | |
Comments | ||
Statistical Test of Hypothesis | p-Value | >0.05 |
Comments | ||
Method | ANOVA | |
Comments |
Title | Anaerobic Bacteria |
---|---|
Description | Subjects brush their teeth with assigned toothpaste 2x/day for 13 days. On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation. Samples of dental plaque at the gumline will be collected for microbiological analysis to determine total levels of anaerobic bacteria CFU - colony forming units. |
Time Frame | 12 hours |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Total Flavor Option 1 | Total Flavor Option 2 | Crest Toothpaste |
---|---|---|---|
Arm/Group Description | Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient - Total Flavor Option 1 Total Flavor option 1: Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient -Total Flavor Option 1 | Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 2 ingredient. Total Flavor Option 2 Total Flavor option 2: Total toothpaste containing triclosan/copolymer/sodium fluoride and new OM complex 2 ingredient. Total Flavor option 2 | Placebo toothpaste: Crest Cavity Protection toothpaste (currently marketed) Placebo toothpaste: Crest Cavity Protection toothpaste: Placebo toothpaste: Crest Cavity Protection toothpaste w/sodium fluoride (currently marketed) |
Measure Participants | 37 | 36 | 34 |
Mean (Standard Error) [colony forming units] |
7.68
(0.09)
|
7.71
(0.09)
|
8.37
(0.09)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Total Flavor Option 2, Crest Toothpaste |
---|---|---|
Comments | The null hypothesis states that there is no difference between groups. | |
Type of Statistical Test | Superiority or Other | |
Comments | ||
Statistical Test of Hypothesis | p-Value | <0.001 |
Comments | ||
Method | ANCOVA | |
Comments |
Title | Malodor Bacteria (Breath Odor Causing Bacteria) |
---|---|
Description | Subjects brush their teeth with assigned toothpaste 2x/day for 13 days. On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation. Samples of dental plaque at the gumline will be collected for microbiological analysis to determine levels of mouth odor causing bacteria CFU - colony forming units. |
Time Frame | Baseline |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Total Flavor Option 1 | Total Flavor Option 2 | Crest Toothpaste |
---|---|---|---|
Arm/Group Description | Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient - Total Flavor Option 1 Total Flavor option 1: Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient -Total Flavor Option 1 | Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 2 ingredient. Total Flavor Option 2 Total Flavor option 2: Total toothpaste containing triclosan/copolymer/sodium fluoride and new OM complex 2 ingredient. Total Flavor option 2 | Placebo toothpaste: Crest Cavity Protection toothpaste (currently marketed) Placebo toothpaste: Crest Cavity Protection toothpaste: Placebo toothpaste: Crest Cavity Protection toothpaste w/sodium fluoride (currently marketed) |
Measure Participants | 37 | 36 | 34 |
Mean (Standard Deviation) [colony forming units] |
6.26
(0.44)
|
6.26
(0.50)
|
6.40
(0.46)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Total Flavor Option 1, Total Flavor Option 2, Crest Toothpaste |
---|---|---|
Comments | The null hypothesis states that there is no difference between groups. | |
Type of Statistical Test | Superiority or Other | |
Comments | ||
Statistical Test of Hypothesis | p-Value | >0.05 |
Comments | ||
Method | ANOVA | |
Comments |
Title | Malodor Bacteria (Breath Odor Causing Bacteria) |
---|---|
Description | Subjects brush their teeth with assigned toothpaste 2x/day for 13 days. On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation. Samples of dental plaque at the gumline will be collected for microbiological analysis to determine levels of mouth odor causing bacteria CFU - colony forming units. |
Time Frame | 12 hours |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Total Flavor Option 1 | Total Flavor Option 2 | Crest Toothpaste |
---|---|---|---|
Arm/Group Description | Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient - Total Flavor Option 1 Total Flavor option 1: Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient -Total Flavor Option 1 | Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 2 ingredient. Total Flavor Option 2 Total Flavor option 2: Total toothpaste containing triclosan/copolymer/sodium fluoride and new OM complex 2 ingredient. Total Flavor option 2 | Placebo toothpaste: Crest Cavity Protection toothpaste (currently marketed) Placebo toothpaste: Crest Cavity Protection toothpaste: Placebo toothpaste: Crest Cavity Protection toothpaste w/sodium fluoride (currently marketed) |
Measure Participants | 37 | 36 | 34 |
Mean (Standard Error) [colony forming units] |
5.99
(0.07)
|
5.92
(0.07)
|
6.32
(0.07)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Total Flavor Option 1, Total Flavor Option 2, Crest Toothpaste |
---|---|---|
Comments | The null hypothesis states that there is no difference between groups. | |
Type of Statistical Test | Superiority or Other | |
Comments | ||
Statistical Test of Hypothesis | p-Value | 0.002 |
Comments | ||
Method | ANCOVA | |
Comments |
Adverse Events
Time Frame | Baseline, 12 hours and 2 weeks | |||||
---|---|---|---|---|---|---|
Adverse Event Reporting Description | ||||||
Arm/Group Title | Total Flavor Option 1 | Total Flavor Option 2 | Crest Toothpaste | |||
Arm/Group Description | Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient - Total Flavor Option 1 Total Flavor option 1: Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient -Total Flavor Option 1 | Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 2 ingredient. Total Flavor Option 2 Total Flavor option 2: Total toothpaste containing triclosan/copolymer/sodium fluoride and new OM complex 2 ingredient. Total Flavor option 2 | Placebo toothpaste: Crest Cavity Protection toothpaste (currently marketed) Placebo toothpaste: Crest Cavity Protection toothpaste: Placebo toothpaste: Crest Cavity Protection toothpaste w/sodium fluoride (currently marketed) | |||
All Cause Mortality |
||||||
Total Flavor Option 1 | Total Flavor Option 2 | Crest Toothpaste | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | / (NaN) | |||
Serious Adverse Events |
||||||
Total Flavor Option 1 | Total Flavor Option 2 | Crest Toothpaste | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/43 (0%) | 0/42 (0%) | 0/43 (0%) | |||
Other (Not Including Serious) Adverse Events |
||||||
Total Flavor Option 1 | Total Flavor Option 2 | Crest Toothpaste | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/43 (0%) | 0/42 (0%) | 0/43 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
Results Point of Contact
Name/Title | Daniel Fine, DMD |
---|---|
Organization | RBHS-Rutgers School of Dental Medicine, Oral Biology Department |
Phone | 973-972-3728 |
finedh@sdm.rutgers.edu |
- CRO-1113-BACT-PS-NJ